LYKALABS.NS
Lyka Labs Ltd
Price:  
111.53 
INR
Volume:  
50,004.00
India | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LYKALABS.NS WACC - Weighted Average Cost of Capital

The WACC of Lyka Labs Ltd (LYKALABS.NS) is 13.3%.

The Cost of Equity of Lyka Labs Ltd (LYKALABS.NS) is 14.25%.
The Cost of Debt of Lyka Labs Ltd (LYKALABS.NS) is 9.55%.

Range Selected
Cost of equity 12.80% - 15.70% 14.25%
Tax rate 17.70% - 31.20% 24.45%
Cost of debt 9.10% - 10.00% 9.55%
WACC 12.1% - 14.6% 13.3%
WACC

LYKALABS.NS WACC calculation

Category Low High
Long-term bond rate 6.9% 7.4%
Equity market risk premium 8.3% 9.3%
Adjusted beta 0.71 0.84
Additional risk adjustments 0.0% 0.5%
Cost of equity 12.80% 15.70%
Tax rate 17.70% 31.20%
Debt/Equity ratio 0.15 0.15
Cost of debt 9.10% 10.00%
After-tax WACC 12.1% 14.6%
Selected WACC 13.3%

LYKALABS.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for LYKALABS.NS:

cost_of_equity (14.25%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.71) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.